Cargando…
Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis
BACKGROUND: The Atopic Dermatitis Control Tool (ADCT©) is a brief patient self-administered instrument designed and validated to assess atopic dermatitis (AD) control; six AD symptoms and impacts are evaluated over the past week, including overall severity of symptoms, days with intense episodes of...
Autores principales: | Simpson, Eric, Eckert, Laurent, Gadkari, Abhijit, Mallya, Usha G., Yang, Min, Nelson, Lauren, Brown, Michelle, Reaney, Matt, Mahajan, Puneet, Guillemin, Isabelle, Boguniewicz, Mark, Pariser, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833284/ https://www.ncbi.nlm.nih.gov/pubmed/31690295 http://dx.doi.org/10.1186/s12895-019-0095-3 |
Ejemplares similares
-
Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children’s Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis
por: Simpson, Eric L., et al.
Publicado: (2019) -
Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
por: Kuznik, Andreas, et al.
Publicado: (2017) -
The infectious complications of atopic dermatitis
por: Wang, Vivian, et al.
Publicado: (2021) -
Effects of variations in access to care for children with atopic dermatitis
por: Siegfried, Elaine C., et al.
Publicado: (2020) -
Efficacy of Dupilumab in severe Atopic Dermatitis (AD) using the AD Control Tool (ADCT) Score in the population of Qatar
por: Joy, Febu, et al.
Publicado: (2023)